BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Prioritizing Back Translation from Bedside to Bench and Novel 
 TargetsWith a whopping 7 approvals in the last two years\, the field is a
 live with positive clinical read outs and the drive to get more life chan
 ging cell engager therapeutics to patients in indications of huge unmet n
 eed.\n\nThe timely 6th Cell Engager Therapeutics Summit is back once agai
 n to meet the needs of the community\, focused on reaching new indication
 s by expanding the target space and focusing our content to novel targets
  as well as continuing the push to focus on the translational challenges 
 of developing cell engager therapies for solid and liquid tumors.\n\nJoin
  100+ of your colleagues from JNJ\, Astellas\, Amgen\, CDR-Life\, Regener
 on\, Immunocore\, Crossbow Therapeutics and AstraZeneca in discovery and 
 translational sciences\, learn from clinical case studies to back transla
 te\, improve engineering by tuning affinity via adapting engager format a
 nd mitigating cytokine release syndrome. This is your one stop shop for a
 ll of the must have content dedicated to all engagers such as T-cell enga
 gers\, BiTe's\, gamma delta engagers and NK engagers.\n\nAs we look to pr
 ioritize the next generation intracellular targets\, how you go about val
 idating\, discovering\, and creating the next therapies to target them\, 
 the power of cell engager technology is clear. Overcome your key challeng
 es in developing cell engagers across three days of highly focused conten
 t - don't miss out!\n\nDate and Time: Tuesday\, 21 May 2024 at 08:00 to T
 hursday\, 23 May 2024 at 17:00\n
DTEND:20240523T170000
DTSTAMP:20260512T214306Z
DTSTART:20240521T080000
LOCATION:Embassy Suites by Hilton Boston at Logan Airport\, 207 Porter Str
 eet\, Boston\, Massachusetts\, 02128\,
SEQUENCE:0
SUMMARY:Prioritizing Back Translation from Bedside to Bench and Novel Targ
 etsWith a whopping 7 approvals in the last two years\, the field is alive
  with pos...
UID:072bb14b-4ebd-4e12-84a2-33f3b093f3c3
END:VEVENT
END:VCALENDAR
